Literature DB >> 568121

Cellular retinol- and retinoic acid-binding proteins in transformed mammalian cells.

J C Saari, S Futterman, G W Stubbs, J T Heffernan, L Bredberg, D Y Chan, D M Albert.   

Abstract

Extracts prepared from several lines of transformed cells were examined for the presence of cellular binding proteins specific for retinoids. Extracts of human retinoblastoma cell line WERI-Rb1 contained a cellular binding protein specific for retinoic acid, whereas extracts of human retinoblastoma cell line Y-79 contained cellular binding proteins for both retinol and retinoic acid. Upon purification, the latter two binding proteins proved to have properties similar to those of the corresponding proteins obtained from bovine retina. Smaller amounts of these binding proteins were detected in extracts of undifferentiated and differentiated neuroblastoma and McCoy cells. HeLa and rat glioma cells had no detectable amount of binding proteins. The 11-cis-retinal-binding protein, present in extracts of human, rat, and bovine retina, was not found in any of the cell lines examined.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 568121

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  4 in total

Review 1.  Histogenesis of retinoblastoma.

Authors:  J Hungerford
Journal:  Br J Ophthalmol       Date:  1990-03       Impact factor: 4.638

2.  HEK293S cells have functional retinoid processing machinery.

Authors:  Lioubov I Brueggemann; Jack M Sullivan
Journal:  J Gen Physiol       Date:  2002-06       Impact factor: 4.086

3.  Specific high-affinity binding and biologic action of retinoic acid in human neuroblastoma cell lines.

Authors:  M Haussler; N Sidell; M Kelly; C Donaldson; A Altman; D Mangelsdorf
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

4.  Binding of retinoids to human breast cancer cell lines and their effects on cell growth.

Authors:  A Lacroix; M E Lippman
Journal:  J Clin Invest       Date:  1980-03       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.